Deena Beasley – Page 4

Bristol drug shrinks melanoma in 31 percent of trial patients

August 24, 2021 at 11:15 a.m.

CHICAGO (Reuters) - An experimental drug from Bristol-Myers Squibb shrank tumors in 31 percent of patients with advanced melanoma, the deadliest form of skin cancer, according to results from an...

Amgen melanoma drug improved survival by 21 percent in interim look

August 24, 2021 at 11:14 a.m.

CHICAGO (Reuters) - Data from a pivotal trial of Amgen Inc's experimental melanoma therapy shows that it improved survival by 21 percent for patients with advanced forms of the deadly...

Immunotherapy is not just for melanoma anymore

May 13, 2019 at 11:48 p.m.

CHICAGO/LOS ANGELES (Reuters) - Diagnosed with advanced lung cancer over a year ago, Gabe Tartaglia was loath to undergo the kind of harsh chemotherapy that had devastated his sister before...

Immunotherapy is not just for melanoma anymore

August 24, 2021 at 10:57 a.m.

CHICAGO/LOS ANGELES (Reuters) - Diagnosed with advanced lung cancer over a year ago, Gabe Tartaglia was loath to undergo the kind of harsh chemotherapy that had devastated his sister before...

Experimental Gilead drug effective in early-stage leukemia trial

August 24, 2021 at 9:43 a.m.

(Reuters) - An experimental drug from Gilead Sciences Inc shrank tumors in half of leukemia patients whose cancer had returned, according to an early-stage trial that represents a new foray...

Experimental Gilead drug effective in early-stage leukemia trial

May 13, 2019 at 11:43 p.m.

(Reuters) - An experimental drug from Gilead Sciences Inc shrank tumors in half of leukemia patients whose cancer had returned, according to an early-stage trial that represents a new foray...

Analysis: Drugmakers face more scrutiny of discordant U.S. prices

May 13, 2019 at 11:43 p.m.

LOS ANGELES (Reuters) - The world's biggest drug makers have for years enjoyed rich premiums for their medicines in the U.S. market. Those days may be coming to an end....

Analysis: Drugmakers face more scrutiny of discordant U.S. prices

August 24, 2021 at 9:48 a.m.

LOS ANGELES (Reuters) - The world's biggest drug makers have for years enjoyed rich premiums for their medicines in the U.S. market. Those days may be coming to an end....

U.S. spending on medicines fell for first time in 2012

May 13, 2019 at 11:48 p.m.

(Reuters) - Patent expirations on big-name drugs such as Lipitor and Plavix has resulted in modestly less spending on medicines in the United States for the first time in at...

U.S. spending on medicines fell for first time in 2012

August 24, 2021 at 11:03 a.m.

(Reuters) - Patent expirations on big-name drugs such as Lipitor and Plavix has resulted in modestly less spending on medicines in the United States for the first time in at...

All Stories